TY - JOUR T1 - SARS-CoV-2 disinfection in aqueous solution by UV<sub>222</sub> from a krypton chlorine excilamp JF - medRxiv DO - 10.1101/2021.02.19.21252101 SP - 2021.02.19.21252101 AU - Richard T. Robinson AU - Najmus Mahfooz AU - Oscar Rosas-Mejia AU - Yijing Liu AU - Natalie M. Hull Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/02/23/2021.02.19.21252101.abstract N2 - There is an urgent need for evidence-based development and implementation of engineering controls to reduce transmission of SARS-CoV-2, the etiological agent of COVID-19. Ultraviolet (UV) light can inactivate coronaviruses, but the practicality of UV light as an engineering control in public spaces is limited by the hazardous nature of conventional UV lamps, which are Mercury (Hg)-based and emit a peak wavelength (254 nm) that penetrates human skin and is carcinogenic. Recent advances in the development and production of Krypton Chlorine (KrCl) excimer lamps hold promise in this regard, as these emit a shorter peak wavelength (222 nm) and are recently being produced to filter out emission above 240 nm. However, the disinfection kinetics of KrCl UV excimer lamps against SARS-CoV-2 are unknown. Here we provide the first dose response report for SARS-CoV-2 exposed to a commercial filtered KrCl excimer light source emitting primarily 222 nm UV light (UV222), using multiple assays of SARS-CoV-2 viability. Plaque infectivity assays demonstrate the pseudo-first order rate constant of SARS-CoV-2 reduction of infectivity to host cells to be 0.64 cm2/mJ (R2 = 0.95), which equates to a D90 (dose for 1 log10 or 90% inactivation) of 1.6 mJ/cm2. Through RT-qPCR assays targeting the nucleocapsid (N) gene with a short (&lt;100 bp) and long (∼1000 bp) amplicon in samples immediately after UV222 exposure, the reduction of ability to amplify indicated an approximately 10% contribution of N gene damage to disinfection kinetics. Through ELISA assay targeting the N protein in samples immediately after UV222 exposure, we found no dose response of the ability to damage the N protein. In both qPCR assays and the ELISA assay of viral outgrowth supernatants collected 3 days after incubation of untreated and UV222 treated SARS-CoV-2, molecular damage rate constants were similar, but lower than disinfection rate constants. These data provide quantitative evidence for UV222 doses required to disinfect SARS-CoV-2 in aqueous solution that can be used to develop further understanding of disinfection in air, and to inform decisions about implementing UV222 for preventing transmission of COVID19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by funds from The Ohio State University (OSU) Sustainability Institute; OSU Infectious Disease Institute; OSU Department of Civil, Environmental, and Geodetic Engineering (Chair: Dr. Allison MacKay); OSU Department of Microbial Infection &amp; Immunity (Chair: Dr. Eugene Oltz); and National Institutes of Health (U54 CA260582). Anna Herman of AquiSense Technologies shared a list of references to SARS-CoV-2 UV disinfection studies. The UV222 light source (USHIO Care222) was provided by USHIO, Inc. through material transfer agreement 2020-2654 to Hull at OSU.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData for UV dose measurements and calculations, absorbance measurements are available in spreadsheet form upon request. Spreadsheet data for plaque assay results, RT-qPCR assay results, and ELISA assay results are available upon request. ER -